Literature DB >> 27733946

Familial primary antiphospholipid syndrome: A report of co-occurrence in three Malaysian family members.

Md Asiful Islam1, Kah Keng Wong2, Teguh Haryo Sasongko1, Siew Hua Gan1, Jin Shyan Wong3.   

Abstract

Here we present a case report of three familial primary antiphospholipid syndrome (PAPS) patients from Malaysia. The three familial patients comprised two females and one male with a mean age of 26.3 years. The first diagnosis was made between 2005 and 2009, and all patients demonstrated deep vein thrombosis, high levels of IgM and IgG anticardiolipin antibodies, and received warfarin treatment international normalized ratio (INR) 2.0-3.0. The patients ceased to show clinical symptoms after treatment. Recently (August 2014), we investigated whether the levels of antiphospholipid antibodies remained elevated, and we found that seronegativity occurred in the patients. We suspect that prolonged anticoagulant treatment might be one of the causes of reduced levels of antiphospholipid antibodies in these familial PAPS patients.

Entities:  

Keywords:  Primary antiphospholipid syndrome; antiphospholipid antibodies; deep vein thrombosis

Year:  2016        PMID: 27733946      PMCID: PMC5058454          DOI: 10.5152/eurjrheum.2015.0068

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  8 in total

Review 1.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.

Authors:  W A Wilson; A E Gharavi; T Koike; M D Lockshin; D W Branch; J C Piette; R Brey; R Derksen; E N Harris; G R Hughes; D A Triplett; M A Khamashta
Journal:  Arthritis Rheum       Date:  1999-07

2.  Seronegative antiphospholipid syndrome.

Authors:  G R V Hughes; M A Khamashta
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

3.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

4.  Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients.

Authors:  R Cervera; M A Khamashta; Y Shoenfeld; M T Camps; S Jacobsen; E Kiss; M M Zeher; A Tincani; I Kontopoulou-Griva; M Galeazzi; F Bellisai; P L Meroni; R H W M Derksen; P G de Groot; E Gromnica-Ihle; M Baleva; M Mosca; S Bombardieri; F Houssiau; J-C Gris; I Quéré; E Hachulla; C Vasconcelos; B Roch; A Fernández-Nebro; J-C Piette; G Espinosa; S Bucciarelli; C N Pisoni; M L Bertolaccini; M-C Boffa; G R V Hughes
Journal:  Ann Rheum Dis       Date:  2008-09-18       Impact factor: 19.103

5.  A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

Authors:  C Kearon; M Gent; J Hirsh; J Weitz; M J Kovacs; D R Anderson; A G Turpie; D Green; J S Ginsberg; P Wells; B MacKinnon; J A Julian
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

6.  "Possible primary antiphospholipid syndrome" with concurrent diffuse alveolar hemorrhaging and Libman-Sacks endocarditis mimicking catastrophic antiphospholipid syndrome.

Authors:  Akitake Suzuki; Naoki Asazuma; Eigo Kikuchi; Takeshi Kawanobe; Yoshihiko Horimoto; Ryuichi Yokobari; Shigeru Kotake; Takahiro Okai
Journal:  Intern Med       Date:  2012-04-01       Impact factor: 1.271

7.  Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Jean-Charles Piette; Josep Font; Munther A Khamashta; Yehuda Shoenfeld; María Teresa Camps; Soren Jacobsen; Gabriella Lakos; Angela Tincani; Irene Kontopoulou-Griva; Mauro Galeazzi; Pier Luigi Meroni; Ronald H W M Derksen; Philip G de Groot; Erika Gromnica-Ihle; Marta Baleva; Marta Mosca; Stefano Bombardieri; Frédéric Houssiau; Jean-Christophe Gris; Isabelle Quéré; Eric Hachulla; Carlos Vasconcelos; Beate Roch; Antonio Fernández-Nebro; Marie-Claire Boffa; Graham R V Hughes; Miguel Ingelmo
Journal:  Arthritis Rheum       Date:  2002-04

8.  Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement.

Authors:  Danxin Wang; Huizi Chen; Kathryn M Momary; Larisa H Cavallari; Julie A Johnson; Wolfgang Sadée
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

  8 in total
  1 in total

Review 1.  Genetics of Antiphospholipid Syndrome.

Authors:  Lourdes Ortiz-Fernández; Amr H Sawalha
Journal:  Curr Rheumatol Rep       Date:  2019-12-05       Impact factor: 4.592

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.